Trump’s tariff warning prompts shift in drug manufacturing to US
Though pharmaceuticals were excluded from recent tariff announcements, the industry is reportedly working with contractors to shift more manufacturing to the US
Teva announces FDA filing acceptance for AJOVY (fremanezumab) in pediatric episodic migraine prevention
J&J’s Tremfya meets primary and secondary endpoints in Phase 3b PsA trial
AstraZeneca’s Imfinzi plus chemo approved to treat lung cancer in EU
GSK partners with ABL Bio to develop neurodegenerative drugs
Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry